All-trans Retinoic Acid Counteracts Diarrhea and Inhibition of Downregulated in Adenoma Expression in Gut Inflammation
Author(s) -
Shubha Priyamvada,
Arivarasu Natarajan Anbazhagan,
Anoop Kumar,
Ishita Chatterjee,
Alip Borthakur,
Seema Saksena,
Ravinder K. Gill,
Waddah A. Alrefai,
Pradeep K. Dudeja
Publication year - 2019
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izz249
Subject(s) - retinoic acid , colitis , inflammation , in vivo , downregulation and upregulation , chemistry , immunology , biology , medicine , pharmacology , cancer research , cell culture , biochemistry , microbiology and biotechnology , gene , genetics
Intestinal epithelial apical membrane Cl-/HCO3- exchanger DRA (downregulated in adenoma, SLC26A3) has emerged as an important therapeutic target for diarrhea, emphasizing the potential therapeutic role of agents that upregulate DRA. All-trans retinoic acid (ATRA), a key vitamin A metabolite, was earlier shown by us to stimulate DRA expression in intestinal epithelial cells. However, its role in modulating DRA in gut inflammation has not been investigated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom